ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2023

Adding PARP inhibitor to an androgen-receptor signaling inhibitor in metastatic prostate cancer: what are we missing?

U De Giorgi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.